Alliance A021901: Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors
Google Scholar   
Citation:
Meeting Instance:
NANETS 2025
Year:
2025
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                   
Networks:
CA016, CA824, LAPS-MA036, LAPS-NY016, LAPS-UT003   
Study
Alliance-A021901
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: